Device Recon Knees

Journey II Xr

Payments companies reported to CMS as associated with Journey II Xr. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.1Massociated payments (2023-2025)
78clinicians with associated payments
1company reporting

By year

2023 $30K
2024 $585K
2025 $520K

Payments reported as associated with Journey II Xr, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $1.0M
Adult Reconstructive Orthopaedic Surgery $101K
Sports Medicine (Orthopaedic Surgery) $20K
Orthopaedic Trauma $3,731
Physician Assistant $202
Pediatrics, Critical Care $129

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Journey II Xr

These are the largest totals companies reported as associated with Journey II Xr. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Jonathan Garino Malvern, PA Orthopaedic Surgery $861,536.69
Jeffery Harpstrite Honolulu, HI Sports Medicine (Orthopaedic Surgery) $19,662.50
Michael Ries Reno, NV Adult Reconstructive Orthopaedic Surgery $14,546.04
Matthew Bullock Huntington, WV Adult Reconstructive Orthopaedic Surgery $14,090.30
Stephen Kim Marietta, GA Orthopaedic Surgery $13,595.00
Anton Kurdin Yuba City, CA Adult Reconstructive Orthopaedic Surgery $13,547.18
Troy Miles Redding, CA Orthopaedic Surgery $13,500.00
Brett Frykberg Jacksonville, FL Orthopaedic Surgery $13,425.00
Todd Grunander Ogden, UT Adult Reconstructive Orthopaedic Surgery $12,900.00
Jeffrey Krempec Kansas City, MO Adult Reconstructive Orthopaedic Surgery $12,487.55

Prescribed Journey II Xr?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.